|
⚲
|
| Keyboard |
| Rankin Aubrey
✚
|
|
|---|---|
| CIK # | 0001818576 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001818576] | |
| 4 | [0001818576] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Revance Therapeutics Inc | |
| Rankin Aubrey |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Revance Therapeutics Inc RVNC
Common Stock
|
2022-03-15 | Tax withheld | 1,372 | $15.79 | 21,664 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-12-03 | Buy | 30,000 | $14.43 | 432,900 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-08-16 | Sell | 9,364 | $26.34 | 246,648 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-08-15 | Tax withheld | 4,949 | $26.02 | 128,773 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-07-28 | Sell | 34,332 | $30.00 | 1,029,960 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-07-28 | Sell | 20,000 | $30.15 | 603,000 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-07-26 | Sell | 55,382 | $29.72 | 1,645,953 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-04-05 | Sell | 2 | $28.28 | 57 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-03-04 | Sell | 33,119 | $25.43 | 842,216 |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2021-02-02 | Grant | 21,540 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-02-02 | Grant | 11,905 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2021-02-01 | Sell | 33,119 | $25.95 | 859,438 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2020-12-30 | Sell | 33,119 | $27.82 | 921,371 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2020-11-30 | Sell | 33,119 | $23.85 | 789,888 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2020-10-29 | Sell | 33,119 | $26.15 | 866,062 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2020-09-28 | Sell | 33,119 | $26.18 | 867,055 |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2020-07-23 | Grant | 8,867 | $2.54 | 22,522 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2020-07-23 | Grant | 610,041 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2020-07-23 | Grant | 57,251 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Employee Stock Option (Right to Buy) · derivative
|
2020-07-23 | Grant | 44,828 | $2.54 | 113,863 |